Read about recent events, essential information and the latest community news.
The new ISBT 128 Standard for the Chain of Identity (CoI) Identifier ( ST-028 ), developed based on requirements developed collaboratively with the Standards Coordinating Body (SCB), has been published. Read more...
OmniaBio expands manufacturing footprint with second Hamilton location January 24, 2023 (Hamilton, ON) – OmniaBio Inc. has expanded its footprint by adding a new process and analytical development Read more...
MicrofluidX and CCRM partner on end-to-end bioprocessing of CAR-T cell therapies Stevenage, UK, and Toronto, Canada, January 11, 2023— MicrofluidX (MFX), a UK-based provider of next-generation bioreactors Read more...
BioCentriq, Inc.—a New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO)—announced today that they've completed a study designed to test transfection of T-cells Read more...
FDA Approves First Gene Therapy to Treat Adults with Hemophilia B: Most Expansive Drug in the World Aisha Khan, PhD Legal and Regulatory Affairs Committee: North America University of Miami Read more...
The challenge of unregulated regenerative medicine – A Latin American Perspective by M. Ignacia Cádiz, MsC Fernando Figueroa, MD Universidad de los Andes Santiago, Chile Over the past decades, Read more...
by Gabrielle O’Sullivan PhD MPH 1 1 Executive Officer Royal Prince Alfred Hospital Institutional Biosafety Committee Royal Prince Alfred Hospital Australia Giulia Giunti PhD 2 2 Quality Read more...
by Gaurav Sutrave, B Sc(Med), MBBS, PhD Staff Specialist Haematologist Westmead Hospital Sydney, Australia The clinical success of CD19 specific chimeric antigen receptor (CAR) T cells and subsequent Read more...
by Whitney Fritzinger, MBA, Education and Training Coordinator Foundation for the Accreditation of Cellular Therapy (FACT) Omaha, NE USA FACT Publishes Third Edition of the Common Standards for Cellular Read more...
Authors: Dr. Mikey Creane (ISCT- Early Stage Professionals Committee) Regenerative Medicine Institute University of Galway Ireland Dr. Rachel Burga (ISCT-Early stage Professionals Committee-Co Read more...